
Staywell Formulation Private Limited
Pharmaceutical company manufacturing a variety of products including syrups, tablets, capsules, and injections.
Pharmaceutical company manufacturing a variety of products including syrups, tablets, capsules, and injections.
Staywell Formulation Private Limited (SFPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 20 November 2007 and has a history of 17 years and five months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.84 Cr.
The company currently has active open charges totaling ₹11.80 Cr. The company has closed loans amounting to ₹6.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vikash Santuka and Suresh Santuka serve as directors at the Company.
Delhi, India
+91-XXXXXXXXXX
U24233DL2007PTC170595
170595
Private Limited Indian Non-Government Company
20 Nov 2007
30 Sep 2024
31 Mar 2024
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vikash Santuka ![]() | Director | 21-Dec-2015 | Current |
Suresh Santuka ![]() | Director | 21-Dec-2015 | Current |
Staywell Formulation Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 52.28% decrease. The company also saw a substantial improvement in profitability, with a 66.79% increase in profit. The company's net worth dipped by a decrease of 7.76%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Staywell Formulation had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Vikash Santuka and Suresh Santuka are mutual person
Vikash Santuka is a mutual person
Suresh Santuka is a mutual person
Suresh Santuka is a mutual person
₹11.80 Cr
₹6.60 Cr
Date | Lender | Amount | Status |
---|---|---|---|
19 Mar 2012 | Dena Bank | ₹11.80 Cr | Open |
27 Mar 2010 | Canara Bank | ₹8.00 M | Satisfied |
30 Mar 2009 | Canara Bank | ₹5.00 M | Satisfied |
30 Mar 2009 | Canara Bank | ₹3.30 Cr | Satisfied |
30 Mar 2009 | Canara Bank | ₹2.00 Cr | Satisfied |
Staywell Formulation has a workforce of 32 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Staywell Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Staywell Formulation's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Staywell Formulation Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Staywell Formulation Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Vikash Kumar Santuka was appointed as a Director was appointed as a Director on 21 Dec 2015 & has been associated with this company since 9 years 4 months .
Suresh Lal Santuka was appointed as a Director was appointed as a Director on 21 Dec 2015 & has been associated with this company since 9 years 4 months .
A charge with Dena Bank of Rs. 11.80 Cr registered on 19 Mar 2012 with Charge ID 10347346 was modified on 30 Dec 2014.
A charge registered on 27 Mar 2010 via Charge ID 10220401 with Canara Bank was fully satisfied on 22 Apr 2013.
Staywell Formulation Private Limited was incorporated on 20 Nov 2007.
The authorized share capital of Staywell Formulation Private Limited is ₹ 3.00 Cr and paid-up capital is ₹ 2.84 Cr.
Currently 2 directors are associated with Staywell Formulation Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Staywell Formulation Private Limited is First Floor 14, Rani Jhansi Road India, New Delhi, 110055.
The corporate identification number (CIN) of Staywell Formulation Private Limited is U24233DL2007PTC170595 and the company number is 170595 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Staywell Formulation Private Limited has fallen by -52.28%.
As Per 2023 financial reports, 32 employees are currently employed by Staywell Formulation Private Limited.
The financial reports for the fiscal year 2023 indicates that The net worth of Staywell Formulation Private Limited has experienced an downturn of -7.76%.
As per the financial statements for fiscal Year 2023, The total open charges for Staywell Formulation Private Limited amount to ₹ 11.80 Cr.
The most recent Balance Sheet for Staywell Formulation Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
NA
VG
AB
TG
SB
VG
UA